Table 6 Subgroup Analysis Major Outcomes
From: Comparison of anticoagulated versus non-anticoagulated patients with intra-aortic balloon pumps
Heparin group (n = 43) | Non-heparin group (n = 45) | p value | |
|---|---|---|---|
Composite endpoint of bleeding | 11 (25.6) | 8 (17.8) | 0.44 |
Major access site bleeding | 1 (2.3) | 2 (4.4) | 1 |
Minor access site bleeding | 3 (6.9) | 2 (4.4) | 1 |
Major non-access site bleeding | 2 (4.7) | 3 (6.7) | 1 |
Minor non-access site bleeding | 5 (11.6) | 1 (2.3) | 0.12 |
Composite endpoint of thrombosis events | 2 (4.7) | 3 (6.7) | 1 |
Limb ischemia | 1 (2.3) | 1 (2.2) | 1 |
Device thrombosis | 0 | 0 | 1 |
VTE | 1 (2.3) | 1 (2.2) | 1 |
Ischemic stroke | 0 | 1 (2.2) | 1 |